Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Bit Mining Ltd. ADR

Start price
Target price
Perf. (%)
€83.00
18.10.21
-
18.01.25
-95.20%
12.01.24

Could be worthwhile Investment >10% per year
buy
Coherus Bioscien.

Start price
Target price
Perf. (%)
€14.60
17.10.21
€20.00
31.12.23
-54.93%
08.05.23

Could be very worthwhile Investment >20% year
4d Pharma plc

Start price
Target price
Perf. (%)
€0.80
17.10.21
€0.60
17.10.22
-15.63%
26.11.21

Could be worthwhile Investment >10% per year
Advicenne

Start price
Target price
Perf. (%)
€7.24
17.10.21
€6.00
17.10.22
-43.92%
18.10.22

Could be worthwhile Investment >10% per year
buy
Gaotu Techedu Inc. ADR

Start price
Target price
Perf. (%)
€2.91
17.10.21
-
17.10.22
-10.65%
30.10.21

Risky Investment
buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€19.80
17.10.21
€25.00
17.10.22
-15.53%
26.11.21

Could be worthwhile Investment >10% per year
Concert Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.44
17.10.21
-
17.10.22
121.23%
28.05.22

Could be worthwhile Investment >10% per year
Durect Corp.

Start price
Target price
Perf. (%)
€1.03
17.10.21
-
17.10.22
-48.06%
18.10.22

Probably not worthwhile Investment
buy
ITM Power plc

Start price
Target price
Perf. (%)
€5.38
16.10.21
€1.00
16.10.22
-79.93%
17.10.22

Medium risks for its business
Innovative
Sustainability is important
Significant cyclical dependencies
buy
Powercell Sweden AB

Start price
Target price
Perf. (%)
€17.40
16.10.21
€18.00
16.10.22
-40.98%
17.10.22

Could be worthwhile Investment >10% per year
Higher risks for its business
buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€9.36
16.10.21
€20.00
16.10.22
47.44%
17.10.22

Could be worthwhile Investment >10% per year
buy
Carisma Therapeutics Inc.

Start price
Target price
Perf. (%)
€16.58
16.10.21
-
16.10.22
22.56%
24.10.21

Could be worthwhile Investment >10% per year
buy
Carisma Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.95
16.10.21
-
16.10.22
-
16.10.21

Could be worthwhile Investment >10% per year
buy
Carisma Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.95
16.10.21
-
16.10.22
-
16.10.21

Could be worthwhile Investment >10% per year
buy
Carisma Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.95
16.10.21
-
16.10.22
-
16.10.21

Could be worthwhile Investment >10% per year
buy
Altamir Amboise

Start price
Target price
Perf. (%)
€23.86
16.10.21
€28.00
16.10.22
-1.78%
17.10.22

Could be worthwhile Investment >10% per year
buy
Marathon Digital Holdings

Start price
Target price
Perf. (%)
€39.35
15.10.21
-
18.01.25
-50.90%
24.01.22

Could be worthwhile Investment >10% per year
Very high cyclical dependencies
buy
Cellectis Nom.

Start price
Target price
Perf. (%)
€9.20
15.10.21
€11.50
15.10.22
-61.67%
07.08.22

Could be worthwhile Investment >10% per year
buy
Kulicke & Soffa Industries Inc.

Start price
Target price
Perf. (%)
€44.20
15.10.21
€60.00
21.10.22
-3.56%
16.06.22

Could be very worthwhile Investment >20% year
Undervalued
Capable Management
Significant cyclical dependencies
buy
Steico SE

Start price
Target price
Perf. (%)
€108.80
13.10.21
€125.00
13.10.22
3.68%
03.11.21

Could be worthwhile Investment >10% per year
Top 10 in its market
Future proof or reliable business model
buy
Psi AG

Start price
Target price
Perf. (%)
€37.00
13.10.21
€42.00
13.10.22
6.49%
18.10.21

Standard Investments for future growth
Innovative
Future proof or reliable business model
Significant cyclical dependencies
McPhy Energy S.A.

Start price
Target price
Perf. (%)
€20.52
13.10.21
€17.00
13.10.22
7.99%
24.10.21

Could be worthwhile Investment >10% per year
buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€30.25
13.10.21
€34.00
30.07.22
-32.13%
14.03.22

Lower EBIT Margin than peer group
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating
buy
Albioma

Start price
Target price
Perf. (%)
€31.78
13.10.21
€35.00
13.10.22
8.06%
26.10.21

Could be worthwhile Investment >10% per year
buy
Kintara Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.99
13.10.21
€1.50
13.10.22
-23.86%
24.10.21

Could be worthwhile Investment >10% per year